Search

everythinglearnresearchcommunity

for

Search:↓

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

European patent law now allows patents for new uses and dosages of known drugs, but protection scope is unclear.

Spironolactone effectively treats female pattern hair loss with few side effects.

Integrating best practices for steroid users in Swiss primary care is feasible and beneficial, but doping laws need change.

The conclusion is that endocrinology significantly impacts medicine with various common medications used for treatment.

Power-enhancing drugs can cause mood swings, aggression, anxiety, and physical side effects, questioning their overall benefits.

Dietary choices, especially fat type, can influence health.

Chronic kidney disease can cause hair loss, which may be related to zinc deficiency or certain medications, and sometimes hair grows back when the underlying issue is treated.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Microneedle technology is beneficial for drug delivery and could make vaccinations cheaper and more accessible.

Most people with Alopecia Areata don't get treatment within a year; it's costly and often comes with other health issues.

Researchers developed a nanomedicine for acne treatment that delivers medication with less irritation and is non-irritating for oily skin.

Manage side effects of hepatitis C treatment with dose changes and medications, which may improve patient adherence and treatment success.

The research found that postmortem root bands in hair are likely caused by the breakdown of a specific part of the hair's inner structure after death.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

The document suggests reevaluating the patent system to ensure public benefits from pharmaceutical privileges and to encourage more significant innovations.

Some alternative medicine treatments might work for skin conditions, but their effectiveness and safety differ a lot.

Androsterone and finasteride have different solid forms, with new findings correcting previous errors and identifying a new form.

In 2024, the FDA approved 50 new drugs, including treatments for hair loss, anemia, high blood pressure, and Alzheimer's.

A 16-year-old girl with autoimmune hemolytic anemia and deep vein thrombosis improved with treatment, possibly indicating systemic lupus erythematosus.

A woman with lupus had blood cell destruction, treated successfully with medication.

Seaweeds have beneficial compounds for skin care, including anti-aging and protective effects.

Oral testosterone therapy raises heart risk more than other methods.

Drug repurposing speeds up drug development, saves money, and has led to about a third of new drug approvals.

The UK Court of Appeal ruled that new dosing regimens for drugs can be patented, aligning with the European Patent Office's approach.

Recent advances show zebrafish can model anemia, Alx4 affects craniofacial and hair development, and mTORC1 is crucial for retinal development.

The revised European Patent Convention may limit generic drug use, affecting healthcare professionals' treatment choices.

Some Greek melanoma patients have gene mutations linked to increased cancer risk, a new color feature helps diagnose melanoma, the incidence of a skin condition in the Netherlands is rare, and a gene possibly affects male-pattern baldness.

Australian court ruled that Bickfords did not infringe on Monster Energy's trade mark because Monster was not sold or known in Australia at the time.